Both in Pharmaceuticals
Heron Therapeutics vs PDS Biotechnology
Over the past year HRTX returned −75.9% and PDSB returned −26.4%; their daily moves had a correlation of 0.10.
HRTX −75.9% PDSB −26.4%Growth of $1, one year, split-adjusted
| Metric | HRTX | PDSB |
|---|---|---|
| Price | $0.3060 | $0.7429 |
| Market cap | $58.1M | $53.8M |
| Today | +4.87% | −3.00% |
| 1 month | −6.3% | +252.3% |
| 6 months | −59.0% | +38.5% |
| Year to date | −76.5% | −3.5% |
| 1 year | −74.7% | −27.2% |
| Revenue growth (YoY) | +1.3% | — |
| Gross margin | 69.3% | — |
| Net margin | −14.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | — |
| Net cash | -$100.0M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 97.3% | 276.2% |
| Short % of float | 30.3% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).